Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023
[193 Pages Report] The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1% during the forecast period. Factors such as rising prevalence of sepsis across the globe, increasing geriatric population, growing government initiatives for creating sepsis awareness, and high incidence of hospital-acquired infections are expected to drive the demand for sepsis diagnosis during the study period.
By technology, the biomarkers segment is expected to grow at the highest rate in the bacterial sepsis diagnosis market during the forecast period
Based on technology, the market is segmented into microbiology, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers. The biomarkers segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the advantages offered by biomarkers such as identification of gram-positive and gram negative infection and helps in differentiating between viral and fungal infections. Also, they help in early identification of sepsis.
By product, the blood culture media segment was the largest contributor to the molecular sepsis diagnostics market market in 2018
The global sepsis diagnostics market is segmented into blood culture media, assays & reagents, instruments, and software. The blood culture media segment commanded the largest share of the global sepsis diagnostics market in 2018. The large share of this segment can be attributed to the increasing use of blood culture testing as the standard diagnostic method for the diagnosis and identification of sepsis
The automated molecular sepsis diagnostics market segment to register higher CAGR during the forecast period
On the basis of methods, the sepsis diagnostics market is categorized into two segments, namely, conventional diagnostics and automated diagnostics. The automated diagnostics segment is expected to grow at the highest CAGR from 2018 to 2023. Accurate detection of positive blood cultures, quick turnaround time, and reduced risk of contamination is contributing to the growth of this segment
Asia Pacific is expected to grow at the highest CAGR in the molecular sepsis diagnostics market during the forecast period
Geographically, the bacterial sepsis diagnosis market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW). The Asia Pacific is one of the major high growth revenue-generating regions in the sepsis diagnostics market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing number of surgical procedures, improving healthcare infrastructure, and rising number of clinical studies in these emerging countries focusing on the diagnosis of various blood-borne infections including sepsis.
Market Dynamics
The sepsis diagnostics market is primarily driven by the rising prevalence of sepsis across the globe. Factors such as the rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and the commercialization and availability of a wide variety of approved sepsis diagnostic devices are also supporting the growth of this market. However, lack of established reimbursement policies for sepsis and the high cost of automated diagnostic devices are the major factors restraining the growth of this market across the globe.
Driver:High incidence of sepsis in adult population
The prevalence of sepsis has increased significantly over the last decade, and the condition is responsible for more number of deaths than other disease conditions, such as bowel and breast cancer combined. The major factors responsible for the significant growth in the prevalence of sepsis include the rising geriatric population, development of drug-resistance among individuals, and rise in virulent varieties of infections. The clinical diagnosis of sepsis infections in geriatric patients is a challenging task. In addition, aging increases the risk of a sudden deterioration in a patients condition from sepsis to severe sepsis and septic shock. Thus, sepsis diagnostic instruments play a key role in the accurate and timely diagnosis of the condition in geriatric patients.
Restraint:High cost of automated diagnostic devices
Every year, a large number of people contract sepsis worldwide, and the mortality rate due to sepsis is very high in comparison with other disease conditions. Early and accurate diagnosis of sepsis is very crucial in patients, as the condition can be managed effectively through proper medication and care. These devices are easy to use, fast, and have advanced features, owing to which they cost more as compared to conventional blood culture tests. For instance, the cost of molecular diagnostic tests is between USD 300 and USD 3,000, which is very high as compared to the cost of blood culture tests that are priced as low as ~USD 2835. Thus, government hospitals (especially in emerging nations) and academic research laboratories generally cannot afford such systems as they have limited budgets, thereby hindering market growth.
Scope of the Report
|
Report Metric |
Details |
|
Market Size Available for Years |
20162023 |
|
Base Year Considered |
2017 |
|
Forecast Period |
20182023 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Technology, Product, Method, Pathogen, Test Type, End Users, and Region |
|
Geographies Covered |
North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW (Latin America and Middle East) |
|
Companies Covered |
bioMιrieux (France), T2 Biosystems (US), Luminex (US), Becton, Dickinson, and Company (US), Roche Diagnostics (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Bruker (US), Abbott Laboratories (US), Immunexpress (Australia), Response Biomedical Corp. (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), Mitsubishi Chemical Europe (Germany), and EKF Diagnostics Holdings (UK). Major 15 players covered. |
This report categorizes the global sepsis diagnostics market into the following segments and subsegments:
Sepsis Diagnostics Market, by Technology
- Microbiology
- Molecular Diagnostics
- Immunoassays
- Flow Cytometry
- Microfluidics
- Biomarkers
Sepsis Diagnostics Market, by Product
- Blood Culture Media
- Assays & Reagents
- Instruments
- Software
Sepsis Diagnostics Market, by Pathogen
- Bacterial Sepsis
- Gram-positive bacteria
- Gram-negative bacteria
- Fungal Sepsis
- Other Pathogens
Sepsis Diagnostics Market, by Method
- Conventional Diagnostics
- Automated Diagnostics
Sepsis Diagnostics Market, by Test Type
- Laboratory Tests
- Point-of-care Tests
Sepsis Diagnostics Market, by End User
- Hospitals
- Pathology & Reference Laboratories
Sepsis Diagnostics Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Rest of Europe (RoE)
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific (RoAPAC)
- Rest of the World (RoW)
- Latin America
- Middle East & Africa
Key Market Players
bioMιrieux (France), Becton, Dickinson, and Company (US), and Danaher (US) dominated the global sepsis diagnostics market in 2016. Other players include T2 Biosystems (US), Luminex (US), Roche Diagnostics (Switzerland), Thermo Fisher Scientific (US), Bruker (US), Abbott Laboratories (US), Immunexpress (Australia), Response Biomedical Corp. (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), Mitsubishi Chemical Europe (Germany), and EKF Diagnostics Holdings (UK), among others.
bioMιrieux SA (France) held the leadership position in the global sepsis diagnostics market in 2016. The company has been focusing new product development and product approvals in the field of sepsis diagnostics. Through this, it introduced innovative products in the market, which enabled it to garner high market share. For instance, bioMιrieux has received approval for several of its products, such as VIDAS BRAHMS PCT (Procalcitonin) assay, VIDAS 3 system, VIRTUO system, and FilmArray 2.0 system to offer enhanced diagnostic solutions for better patient care. These launches helped the company strengthen its product portfolio and presence in the sepsis diagnostics market.
Becton, Dickinson, and Company (US) held the second position in the global sepsis diagnostics market in 2016. The company has a diversified portfolio, which includes automated blood culture instruments, blood culture medium, blood culture consumables, and laboratory data management software. The companys leadership position in the market can be attributed to its strong distribution network in both developed as well as developing countries across the globe, which enables it to serve customers in North America, Europe, Asia Pacific, Eastern Europe, the Middle East, and Africa.
Recent Developments:
- In 2018, Immunexpress partnered with Biocartis (Belgium) for the development and marketing of SeptiCyte test for using it on Biocartiss sample-to-result Idylla platform. This helped the company to expand its offerings across the globe.
- In 2017, bioMιrieux SA (France) received FDA approval for its BacT/ALERT VIRTUO fully automated blood culture system. This helped the company to cater to the increasing demand for sepsis diagnostics across the globe.
- In 2017, Bruker (US) acquired InVivo Biotech Services GmbH (Germany) to expand its microbiology assay menu for its MALDI Biotyper platform.
Key Questions Addressed by the Report:
- What are the growth opportunities related to the adoption of sepsis diagnosis across major regions in the future?
- Emerging countries have immense opportunities for the growth and adoption of technologically advanced (automated) diagnostic systems. Will this scenario continue in the next five years?
- Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
- What are the new trends and advancements in the sepsis diagnostics market? Are there any new advanced products being developed for early diagnosis?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 24)
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.4.1 Years Considered For The Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders
2 Research Methodology (Page No. - 27)
2.1 Research Data
Figure 1 Global Sepsis Diagnostics Market: Research Methodology Steps
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
Figure 2 Breakdown Of Primary Interviews: By Company Type,Designation,And Region
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.3 Market Size Estimation Methodology
2.1.4 Bottom-Up Approach
2.1.5 Top-Down Approach
2.1.6 Research Design
2.1.7 Market Data Validation And Triangulation
Figure 3 Data Triangulation Methodology
2.1.8 Assumptions For The Study
3 Executive Summary (Page No. - 37)
Figure 4 Global Sepsis Diagnostics Market,By Product,2018
Figure 5 Global Sepsis Diagnostics Market,By Technology,2023
Figure 6 Global Sepsis Diagnostics Market,By Method,2018
Figure 7 Global Sepsis Diagnostics Market,By Test Type,2018 Vs. 2023
Figure 8 Global Sepsis Diagnostics Market,By Pathogen,2018
Figure 9 Global Sepsis Diagnostics Market,By End User,2018
Figure 10 Global Sepsis Diagnostics Market,By Region,2018 (Usd Million)
4 Premium Insights (Page No. - 42)
4.1 Sepsis Diagnostics: Market Overview
Figure 11 Rising Prevalence Of Sepsis Is Driving The Growth Of Sepsis Diagnostics Market Across The Globe
4.2 Sepsis Diagnostics Market,By Technology
Figure 12 Microbiology Segment Will Continue To Dominate The Market In 2023
4.3 Geographic Analysis: Sepsis Diagnostics Market,By Product And Region
Figure 13 Blood Culture Media Segment To Dominate The Global Sepsis Diagnostics Products Market In 2018
4.4 Sepsis Diagnostics Market,By Pathogen
Figure 14 Bacterial Sepsis Segment To Dominate The Sepsis Diagnostics Market During The Forecast Period
4.5 Sepsis Diagnostics Market,By Method
Figure 15 Conventional Diagnostics Method To Dominate The Sepsis Diagnostics Market During The Forecast Period
4.6 Geographic Snapshot Of The Sepsis Diagnostics Market
Figure 16 Asia Pacific To Register The Highest Cagr During The Forecast Period
5 Market Overview (Page No. - 46)
5.1 Introduction
5.2 Market Dynamics
Figure 17 Sepsis Diagnostics Market: Drivers,Restraints,Opportunities,And Challenges
5.2.1 Drivers
5.2.1.1 High Incidence Of Sepsis In The Adult Population
5.2.1.1 Increasing Incidence Of Sepsis In Neonates
5.2.1.2 Growing Incidence Of Hospital-Acquired Infections
5.2.1.3 Increasing Number Of Surgical Procedures
5.2.1.4 Increasing Burden Of Pneumonia
5.2.1.5 Influx Of Novel Sepsis Diagnostic Products
5.2.1.6 Rising Initiatives To Increase The Awareness And Drive The Adoption Of Sepsis Diagnostic Tests
5.2.1.7 Funding For Sepsis-Related Research Activities
5.2.2 Restraints
5.2.2.1 Lack Of Established Reimbursement Policies For Sepsis
5.2.2.2 High Cost Of Automated Diagnostic Devices
5.2.3 Opportunities
5.2.3.1 Development Of Rapid Diagnostic/Poc Techniques For Early Sepsis Diagnosis
5.2.3.2 Evolution Of Novel Biomarkers For Sepsis Diagnosis
5.2.4 Challenges
5.2.4.1 Lack Of Standard Protocols And Awareness For Sepsis Diagnosis And Treatment
5.2.4.2 Shortage Of Skilled Healthcare Professionals
6 Sepsis Diagnostics Market,By Technology (Page No. - 57)
6.1 Introduction
Figure 18 Biomarkers Segment To Witness The Highest Growth During The Forecast Period
Table 1 Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
6.2 Microbiology
Table 2 Microbiology Market For Sepsis Diagnosis,By Region,20162023 (Usd Million)
6.3 Molecular Diagnostics
6.3.1 Polymerase Chain Reaction
6.3.2 Peptide Nucleic Acid-Fluorescent In Situ Hybridization
6.3.3 Microarrays
6.3.4 Syndromic Panel-Based Testing
Table 3 Molecular Diagnostics Market For Sepsis Diagnosis,By Region,20162023 (Usd Million)
6.4 Immunoassay
Table 4 Immunoassay Market For Sepsis Diagnosis,By Region,20162023 (Usd Million)
6.5 Flow Cytometry
Table 5 Flow Cytometry Market For Sepsis Diagnosis,By Region,20162023 (Usd Million)
6.6 Microfluidics
Table 6 Microfluidics Market For Sepsis Diagnosis,By Region,20162023 (Usd Million)
6.7 Biomarkers
Table 7 Biomarkers Market For Sepsis Diagnosis,By Region,20162023 (Usd Million)
7 Sepsis Diagnostics Market,By Product (Page No. - 66)
7.1 Introduction
Figure 19 Blood Culture Media Segment To Witness Highest Growth During The Forecast Period
Table 8 Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
7.2 Instruments
Table 9 Sepsis Diagnostic Instruments Market,By Region,20162023 (Usd Million)
7.3 Blood Culture Media
Table 10 Sepsis Diagnostic Blood Culture Media Market,By Region,20162023 (Usd Million)
7.4 Assays & Reagents
Table 11 Sepsis Diagnostic Assays & Reagents Market,By Region,20162023 (Usd Million)
7.5 Software
Table 12 Sepsis Diagnostic Software Market,By Region,20162023 (Usd Million)
8 Sepsis Diagnostics Market,By Method (Page No. - 73)
8.1 Introduction
Figure 20 Conventional Diagnostics Segment To Dominate The Sepsis Diagnostics Market In 2023
Table 13 Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
8.2 Conventional Diagnostics
Table 14 Conventional Diagnostics Market,By Region,20162023 (Usd Million)
8.3 Automated Diagnostics
Table 15 Automated Diagnostics Market,By Region,20162023 (Usd Million)
9 Sepsis Diagnostics Market,By Pathogen (Page No. - 78)
9.1 Introduction
Figure 21 Bacterial Sepsis Segment To Register The Highest Growth Rate During The Forecast Period
Table 16 Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
9.2 Bacterial Sepsis
Table 17 Bacterial Sepsis Market,By Type,20162023 (Usd Million)
Table 18 Bacterial Sepsis Market,By Region,20162023 (Usd Million)
9.2.1 Gram-Negative Bacterial Sepsis
Table 19 Bacterial Causes Of Adult Sepsis
9.2.2 Gram-Positive Bacterial Sepsis
Table 20 Bacterial Causes Of Adult Sepsis
9.3 Fungal Sepsis
Table 21 Fungal Sepsis Market,By Region,20162023 (Usd Million)
9.4 Other Pathogens
Table 22 Other Pathogens Market,By Region,20162023 (Usd Million)
10 Sepsis Diagnostics Market,By Test Type (Page No. - 85)
10.1 Introduction
Figure 22 Point-Of-Care Tests Segment To Grow At The Highest Cagr
Table 23 Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
10.2 Laboratory Tests
Table 24 Laboratory Pointers Of Sepsis
Table 25 Laboratory Tests Market,By Region,20162023 (Usd Million)
10.3 Point-Of-Care Tests
Table 26 Point-Of-Care Tests Market,By Region,2016-2023 (Usd Million)
11 Sepsis Diagnostics Market,By End User (Page No. - 91)
11.1 Introduction
Figure 23 Hospitals Segment To Dominate The Sepsis Diagnostics Market In 2023
Table 27 Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
11.2 Hospitals
Table 28 Sepsis Diagnostics Market For Hospitals,By Region,20162023 (Usd Million)
11.3 Pathology & Reference Laboratories
Table 29 Sepsis Diagnostics Market For Pathology & Reference Laboratories,By Region,20162023 (Usd Million)
12 Sepsis Diagnostics Market,By Region (Page No. - 95)
12.1 Introduction
Figure 24 Sepsis Incidence,By Country,2017
Figure 25 Sepsis Diagnostics Market: Growth Forecast,By Region (20182023)
Table 30 Sepsis Diagnostics Market,By Region,20162023 (Usd Million)
12.2 North America
Figure 26 North America: Sepsis Diagnostics Market Snapshot
Table 31 North America: Sepsis Diagnostics Market,By Country,20162023 (Usd Million)
Table 32 North America: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 33 North America: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 34 North America: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 35 North America: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 36 North America: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 37 North America: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.2.1 Us
Table 38 Us: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 39 Us: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 40 Us: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 41 Us: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 42 Us: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 43 Us: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.2.2 Canada
Table 44 Canada: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 45 Canada: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 46 Canada: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 47 Canada: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 48 Canada: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 49 Canada: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.3 Europe
Figure 27 Europe: Sepsis Diagnostics Market Snapshot
Table 50 Europe: Sepsis Diagnostics Market,By Country,20162023 (Usd Million)
Table 51 Europe: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 52 Europe: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 53 Europe: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 54 Europe: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 55 Europe: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 56 Europe: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.3.1 Germany
Table 57 Germany: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 58 Germany: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 59 Germany: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 60 Germany: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 61 Germany: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 62 Germany: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.3.2 France
Table 63 France: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 64 France: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 65 France: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 66 France: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 67 France: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 68 France: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.3.3 Uk
Table 69 Uk: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 70 Uk: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 71 Uk: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 72 Uk: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 73 Uk: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 74 Uk: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.3.4 Rest Of Europe (Roe)
Table 75 Roe: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 76 Roe: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 77 Roe: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 78 Roe: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 79 Roe: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 80 Roe: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.4 Asia Pacific
Figure 28 Apac: Sepsis Diagnostics Market Snapshot
Table 81 Apac: Sepsis Diagnostics Market,By Country,20162023 (Usd Million)
Table 82 Apac: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 83 Apac: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 84 Apac: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 85 Apac: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 86 Apac: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 87 Apac: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.4.1 Japan
Table 88 Japan: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 89 Japan: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 90 Japan: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 91 Japan: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 92 Japan: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 93 Japan: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.4.2 China
Table 94 China: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 95 China: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 96 China: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 97 China: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 98 China: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 99 China: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.4.3 India
Table 100 India: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 101 India: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 102 India: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 103 India: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 104 India: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 105 India: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.4.4 Rest Of Asia Pacific
Table 106 Roapac: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 107 Roapac: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 108 Roapac: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 109 Roapac: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 110 Roapac: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 111 Roapac: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.5 Rest Of The World
Table 112 Row: Sepsis Diagnostics Market,By Region,20162023 (Usd Million)
Table 113 Row: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 114 Row: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 115 Row: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 116 Row: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 117 Row: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 118 Row: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.5.1 Latin America
Table 119 Latin America: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 120 Latin America: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 121 Latin America: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 122 Latin America: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 123 Latin America: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 124 Latin America: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
12.5.2 Middle East & Africa
Table 125 Middle East & Africa: Sepsis Diagnostics Market,By Technology,20162023 (Usd Million)
Table 126 Middle East & Africa: Sepsis Diagnostics Market,By Product,20162023 (Usd Million)
Table 127 Middle East & Africa: Sepsis Diagnostics Market,By Pathogen,20162023 (Usd Million)
Table 128 Middle East & Africa: Sepsis Diagnostics Market,By Method,20162023 (Usd Million)
Table 129 Middle East & Africa: Sepsis Diagnostics Market,By Test Type,20162023 (Usd Million)
Table 130 Middle East & Africa: Sepsis Diagnostics Market,By End User,20162023 (Usd Million)
13 Competitive Landscape (Page No. - 149)
13.1 Overview
Figure 29 Key Developments By Leading Market Players In The Sepsis Diagnostics Market,20152017
13.2 Market Share Analysis
Figure 30 Sepsis Diagnostics Market Share,By Key Players,2016
13.3 Competitive Scenario
13.3.1 Product Launches And Approvals,20152017
13.3.2 Partnerships And Collaborations,20152018
13.3.3 Mergers And Acquisitions
14 Company Profiles (Page No. - 153)
(Business Overview, Products Offered, Recent Developments, and MnM View)*
14.1 Biomιrieux
Figure 31 Biomιrieux: Company Snapshot
14.2 T2 Biosystems
Figure 32 T2 Biosystems: Company Snapshot
14.3 Luminex
Figure 33 Luminex: Company Snapshot
14.4 Becton,Dickinson,And Company (Bd)
Figure 34 Bd: Company Snapshot
14.5 Roche Diagnostics (A Subsidiary Of F. Hoffmann-La Roche Ltd.)
Figure 35 Roche Diagnostics: Company Snapshot
14.6 Danaher
Figure 36 Danaher: Company Snapshot
14.7 Thermo Fisher Scientific
Figure 37 Thermo Fisher Scientific: Company Snapshot
14.8 Bruker
Figure 38 Bruker: Company Snapshot
14.9 Abbott
Figure 39 Abbott: Company Snapshot
14.1 Immunexpress
14.11 Response Biomedical
14.12 Axis-Shield Diagnostics
14.13 Cytosorbents
Figure 40 Cytosorbents: Company Snapshot
14.14 Mitsubishi Chemical Europe
14.15 Ekf Diagnostics
Figure 41 Ekf Diagnostics: Company Snapshot
*Details on Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
15 Appendix (Page No. - 189)
15.1 Discussion Guide
15.2 Knowledge Store: Marketsandmarkets Subscription Portal
15.3 Introducing Rt: Real-Time Market Intelligence
15.4 Available Customizations
15.5 Related Reports
15.6 Author Details
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Sepsis Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Sepsis Diagnostics Market